These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 24058118)

  • 1. Theorising beyond the individual: adherence to antiretroviral therapy in resource-constrained societies.
    Kagee A; Swartz A; Swartz L
    J Health Psychol; 2014 Jan; 19(1):103-9. PubMed ID: 24058118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural barriers to adherence to antiretroviral therapy in a resource-constrained setting: the perspectives of health care providers.
    Coetzee B; Kagee A; Vermeulen N
    AIDS Care; 2011 Feb; 23(2):146-51. PubMed ID: 21259126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Barriers to antiretroviral therapy adherence in developed countries: a qualitative synthesis to develop a conceptual framework for a new patient-reported outcome measure.
    Engler K; Lènàrt A; Lessard D; Toupin I; Lebouché B
    AIDS Care; 2018; 30(sup1):17-28. PubMed ID: 29719990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient-reported barriers and drivers of adherence to antiretrovirals in sub-Saharan Africa: a meta-ethnography.
    Merten S; Kenter E; McKenzie O; Musheke M; Ntalasha H; Martin-Hilber A
    Trop Med Int Health; 2010 Jun; 15 Suppl 1():16-33. PubMed ID: 20586957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Piloting behavioral family systems therapy to improve adherence among adolescents with HIV: a case series intervention study.
    Gray WN; Janicke DM; Fennell EB; Driscoll DC; Lawrence RM
    J Health Psychol; 2011 Jul; 16(5):828-42. PubMed ID: 21441357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is antiretroviral therapy cost-effective in South Africa?
    Braithwaite RS; Tsevat J
    PLoS Med; 2006 Jan; 3(1):e60. PubMed ID: 16435892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strategies for the scale-up of antiretroviral therapy in South Africa through health system optimization.
    Barker PM; McCannon CJ; Mehta N; Green C; Youngleson MS; Yarrow J; Bennett B; Berwick DM
    J Infect Dis; 2007 Dec; 196 Suppl 3():S457-63. PubMed ID: 18181694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gender and other psychosocial factors as predictors of adherence to highly active antiretroviral therapy (HAART) in adults with comorbid HIV/AIDS, psychiatric and substance-related disorder.
    Applebaum AJ; Richardson MA; Brady SM; Brief DJ; Keane TM
    AIDS Behav; 2009 Feb; 13(1):60-5. PubMed ID: 18690532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pill taking from the perspective of HIV-Infected women who are vulnerable to antiretroviral treatment failure.
    Stevens PE; Hildebrandt E
    Qual Health Res; 2009 May; 19(5):593-604. PubMed ID: 19258590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of anger in adherence to highly active antiretroviral treatment in patients infected with HIV.
    Leombruni P; Fassino S; Lavagnino L; Orofino G; Morosini P; Picardi A
    Psychother Psychosom; 2009; 78(4):254-7. PubMed ID: 19468260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acceptance-based behavior therapy to promote HIV medication adherence.
    Moitra E; Herbert JD; Forman EM
    AIDS Care; 2011 Dec; 23(12):1660-7. PubMed ID: 21732897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adherence as therapeutic citizenship: impact of the history of access to antiretroviral drugs on adherence to treatment.
    Nguyen VK; Ako CY; Niamba P; Sylla A; Tiendrébéogo I
    AIDS; 2007 Oct; 21 Suppl 5():S31-5. PubMed ID: 18090265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-infected patients' adherence to highly active antiretroviral therapy: a phenomenological study.
    Mohammadpour A; Yekta ZP; Nikbakht Nasrabadi AR
    Nurs Health Sci; 2010 Dec; 12(4):464-9. PubMed ID: 21210925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient readiness to adhere to HAART.
    Grimes RM; Grimes DE
    J Int Assoc Physicians AIDS Care (Chic); 2009; 8(6):364-6. PubMed ID: 19952288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The development of an inventory to assess the structural barriers to clinic attendance and pill-taking amongst users of antiretroviral therapy.
    Coetzee B; Kagee A
    AIDS Behav; 2013 Jan; 17(1):319-28. PubMed ID: 23229338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adherence is key to HIV treatment.
    Khakha DC
    Nurs J India; 2008 Jun; 99(6):125-7. PubMed ID: 19127906
    [No Abstract]   [Full Text] [Related]  

  • 17. The cost of antiretroviral drugs and influence on prescribing policies.
    Jones R; Gazzard B
    Int J STD AIDS; 2006 Aug; 17(8):499-506. PubMed ID: 16925892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beliefs about antiretroviral therapy, treatment adherence and quality of life in a 48-week randomised study of continuation of zidovudine/lamivudine or switch to tenofovir DF/emtricitabine, each with efavirenz.
    Cooper V; Moyle GJ; Fisher M; Reilly G; Ewan J; Liu HC; Horne R;
    AIDS Care; 2011 Jun; 23(6):705-13. PubMed ID: 21476152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. "Nothing new": responses to the introduction of antiretroviral drugs in South Africa.
    Chopra M; Kendall C; Hill Z; Schaay N; Nkonki LL; Doherty TM
    AIDS; 2006 Oct; 20(15):1975-7. PubMed ID: 16988520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of adherence to antiretroviral treatment and therapeutic success among children in South Africa.
    Muller AD; Bode S; Myer L; Stahl J; von Steinbuchel N
    AIDS Care; 2011 Feb; 23(2):129-38. PubMed ID: 20645192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.